John M. Sprague, Chief Financial Officer at T2 Biosystems, Inc. (TTOO), sold 2,693 shares at $0.65 ($2K) on 2023-02-22, disclosed to the SEC on 2023-03-09.
Scheduled sale ($2k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.65 | 1,545 | $1K | 59.7% |
| 2 | $0.59 | 1,148 | $677 | 40.3% |
| Total | $0.62 avg | 2,693 | $2K | 100% |
| Filing → |
| TTOO | SELL | 2020-03-03 | $3K | — | Filing → |